Pharmafluidics Appoints Fasha Mahjoor
Pharmafluidics has announced the appointment of Fasha Mahjoor as an independent director.
Pharmafluidics has announced the appointment of Fasha Mahjoor as an independent director. Founder of Phenomenex, Mahjoor has over 30 years’ experience in the analytical science market and built Phenomenex into a company that currently employs 780 people with subsidiary companies in 16 other countries, and a network of 60 international partners.
Mahjoor agreed to sell his company to Danaher Corporation in 2016 and stayed on as President until July 2017 to ensure a smooth transition. Explaining his choice to take on this new role, Mahjoor described Pharmafluidic’s work as a “paradigm shift in this field” and incredibly “intriguing” to him.
“I was always on the lookout for the next breakthrough and frankly always a bit concerned as what may displace a conventional high performance liquid chromatography (HPLC) column as we know it today,” said Mahjoor. “I was keen to learn a lot more about this fascinating micro-pillar array technology and how it may affect the industry.”
Launching in June 2017, Pharmafluidic’s microâpillar array columns have already garnered much attention within the separation science community, but the company still has a lot of challenges ahead. “At this moment [the challenge] is to scale and to provide wide commercial access of their products to an increasing number of chromatography users,” explained Mahjoor. “First in the field of proteomics, biomarkers, and biopharmaceuticals applications, and then through further product generations also to all other market segments, for example, in quality control or ultrahighâpressure liquid chromatography (UHPLC) applications, across industries.”
It is in this area that Mahjoor believes his experience can be invaluable to Pharmafluidics. “I spent my entire working career in chromatography”
“I can assist and provide much guidance to Pharmafluidics and on many fronts,” explained Mahjoor, citing his “vast market knowledge and experience with customers adopting to new technologies” as key skills he can offer.
Katleen Verleysen, Chair of Pharmafluidics, added, “We are excited to welcome Fasha Mahjoor to our board of directors, his association endorsing the value of Pharmafluidics and its technology.”
“Mr. Mahjoor has demonstrated true leadership throughout his career realizing impressive commercial and business successes, and we expect him to make key contributions to the further international development of Pharmafluidics,” said Verleysen.
For more information about Pharmafluidics please visit: www.pharmafluidics.com
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
Liquid Chromatography to Analyze Vitamin D Proteins in Psoriasis Patients
January 21st 2025Can a protein involved in delivering Vitamin D to target tissues have an altered serum profile in psoriasis patients with cardiovascular disease? Researchers used liquid chromatography (LC) to help find out.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
